Companion Diagnostics Market Size, Share, Growth Analysis, By Product and Services (Assays, Kits, Reagents, and Software & Services), By Technology (PCR and ISH), By Indication (Cardiovascular and oncology), By Region - Industry Forecast 2025-2032

Significantly, the sales are in North America, amounting to USD 2.35 billion in 2023. Some of the factors that give explanations for the mentioned regional dominance include the increased prevalence of chronic diseases such as cancer in North America compared to other regions. The global healthcare landscape's expanding tendencies toward precision medicine are driving the launch of novel Companion Diagnostic (CDx) assays. The definition of the precise patient care intervention techniques employed in patient care has been substantially improved using these advanced diagnostic tools. In the healthcare industry, bioplastics are utilized to produce diagnostic equipment and medical devices. This is because bioplastics can adhere to stringent healthcare regulations and are more environmentally friendly. As precision medicine advances, probability of greater need for advanced diagnostic instruments and the materials required to create them, such as bioplastics, is expected to solidify North America's leading position in the market. 

Asia-Pacific is expected to grow at the fastest rate during the forecast period. This specific growth path can be associated with several interconnected factors. First and foremost, there has been a noticeable increase in cancer incidence in the area, along with the development of improved diagnostic instruments and CDx assays. The increased application of bioplastics has resulted from an increase in demand for advanced medical testing. It provides both efficient performance and sustainable growth. Bioplastics are increasingly being adopted in the making of medical instruments and diagnostic equipment. These meet environmental standards and pass health guidelines. Growing investments by the region in medical technology and healthcare infrastructure are further impelling the studies and applications of bioplastics.